Thesis (Ph. D.)--University of Missouri-Columbia, 2003. / Typescript. Vita. Includes bibliographical references (leaves 87-88). Also available on the Internet.

Thesis (Ph. D.)--University of Missouri-Columbia, 2003. / Typescript. Vita. Includes bibliographical references (leaves 87-88). Also available on the Internet.

n-3 polyunsaturated fatty acids (n-3 PUFA) have been postulated to improve the insulin resistance associated with type 2 diabetes since the 1960s when observational studies in the Alaskan Inuit noted a reduced prevalence of type 2 diabetes when this population consumed a traditional diet. These findings were supported by animal studies but results of human intervention studies have been variable with most showing no change in glucose metabolism. More recent studies in growing farm animals suggested that muscle membrane phospholipids required to be enriched to a minimum of 14% n-3 PUFA in order for a change in insulin sensitivity to occur. This study sought to establish the effect of long-term (9 month) high-dose (3g/day) supplement of the n-3 PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on insulin sensitivity of glucose and protein metabolism. Thirty-three subjects with impaired glucose regulation underwent hyperinsulinaemic-euglycaemic-euaminoacidaemic clamps pre- and postintervention of n-3 PUFA or a control (maize) oil. A second cohort who all received n-3 PUFA supplementation underwent pre- and post-intervention muscle biopsies. Secondary outcomes included an assessment of inflammatory status and determining whether erythrocyte membrane phospholipid could act as a surrogate for muscle membrane phospholipid. In the clamp cohort, there were no changes in glucose metabolism postintervention; however, there was an increase in insulin-stimulated protein metabolism following the fish oil intervention. In the biopsy cohort, no subject achieved 14% PUFA enrichment in muscle membrane phospholipids; however, all subjects who received n-3 PUFA supplementation did achieve a minimum of 14% enrichment of n-3 PUFA in erythrocyte membrane phospholipid. In agreement with the majority of the literature, n-3 PUFA did not affect glucose metabolism. Insulin-stimulated protein metabolism was improved supporting the findings of another recent human study. These changes in protein metabolism may reduce the sarcopenia associated with aging, potentially delaying the progression of frailty.

Type II polyketide synthases (PKSs) are responsible for the generation of structurally diverse and clinically important aromatic polyketides. The bacteriostatic agent enterocin (enc) isolated from the marine microbe "Streptomyces maritimus" is derived from a rare benzoate primer unit and contains a unique nonaromatic caged core structure resulting from a Favorskii-like carbon skeleton rearrangement. The apparent diversion between enterocin biosynthesis and all other type II PKS pathways offered the opportunity to discover novel enzymatic strategies that may be exploited to diversify the chemical structures of polyketides. A comprehensive biochemical analysis was performed in order to characterize the key steps in enterocin biosynthesis and finally to reconstitute the whole pathway in vitro using purified recombinant enzymes.A nonribosomal peptide synthetase (NRPS)-like priming mechanism was discovered for the selective activation of a benzoic acid starter unit and its subsequent attachment to the enc PKS to initiate polyketide biosynthesis. This is the first example of a type II PKS that employs an NPRS-like priming mechanism to utilize alternative non- acetate starter units. Secondly, the minimal enc PKS was reconstituted in vitro to give three novel acetate-primed metabolites that had never been identified by heterologous in vivo expression of recombinant enc PKS gene sets. The minimal enc PKS was then merged with the NRPS-like chain initiation module and the resulting multienzyme complex catalyzed the formation of benzoate-primed natural products wailupemycin F and wailupemycin G. Favorskii-like rearrangement of the nascent polyketide chain was replicated in vitro and the flavin-dependent oxygenase EncM was confirmed to be solely responsible for catalyzing this unprecedented rearrangement. Other biosynthetic steps in the late stage of the enc pathway were also replicated in vitro, including the methylation of desmethyl-5-deoxyenterocin to 5-deoxyenterocin and the hydroxylation of 5-deoxyenterocin to enterocin.Finally, the entire enc type II PKS pathway was successfully assembled in vitro using ten recombinant proteins and three commercial enzymes. Five enc-based natural products were generated from benzoic acid and malonyl-coenzyme A. This biochemical investigation on enterocin biosynthesis represents the first complete in vitro reconstitution of a type II PKS system and also provides an alternative strategy to create complex natural products by multienzyme synthesis.

Inflammation of the central nervous system (CNS) is important in many human diseases, and is regulated by a multitude of factors, including the cytokine interferon-gamma (IFNgamma). The importance of IFNgamma is highlighted in experimental autoimmune encephalomyelitis (EAE), an animal model of CNS inflammation. Mice lacking IFNgamma show exaggerated disease, with a different pattern of chemokine expression than the wild-type. We administered IFNgamma to the CNS using intrathecal injection of a replication-defective adenoviral vector to ask about direct actions of IFNgamma on chemokine expression without the confounding factors present during CNS inflammation. AdIFNgamma induced expression of CXCL10 and CCL5, two chemokines strikingly absent in Ifng-/- EAE. Chemokine expression was not associated with inflammation, though when an infectious stimulus was administered, an influx of immune cells to the CNS was seen. Using AdIFNgamma to restore IFNgamma to Ifng-/- mice with EAE had a disease-limiting effect. We used vectors encoding CXCL10 or CCL5, to replace these chemokines which are absent during Ifng-/- EAE, attempting to modulate the disease into a form resembling that of the wild-type. AdCCL5 treatment showed a mild reduction in EAE severity in the Ifng-/-, though AdCXCL10 treatment had no effect. A principal inducer of IFNgamma is interleukin-18 (IL 18), and IFNgamma induces IL18-binding protein (IL18bp) which inhibits IL18, establishing a negative feedback loop. We found that ILl8bp expression is upregulated in wild-type mice with EAE, but not in the Ifng-/-, suggesting that the exaggerated disease of the Ifng -/- may be due in part to unrestrained actions of ILI8. Treatment with a vector encoding IL18bp (AdIL18bp) significantly inhibited EAE, without restricting immune cell entry to the CNS. Cytokine expression was shifted away from a pattern favouring Th17 development. AdIL18bp treatment inhibited EAE in Ifng-/- mice, indicating that IFNgamma was not required for this activity. We used a vector encoding M3, a chemokine-binding protein derived from MHV-68, to reduce EAE severity, showing the first use of a viral chemokine-binding protein in EAE.

The DNA microarray biotechnology simultaneously monitors the expression of thousands of genes and aims to identify genes that are differently expressed under different conditions. From the statistical point of view, it can be restated as identify genes strongly associated with the response or covariant of interest. The Gene Set Enrichment Analysis (GSEA) method is one method which focuses the analysis at the functional related gene sets level instead of single genes. It helps biologists to interpret the DNA microarray data by their previous biological knowledge of the genes in a gene set. GSEA has been shown to efficiently identify gene sets containing known disease-related genes in the real experiments. Here we want to evaluate the statistical power of this method by simulation studies. The results show that the the power of GSEA is good enough to identify the gene sets highly associated with the response or covariant of interest.

Le système de sécrétion de type II (T2SS) est largement exploité par les bactéries à Gram négatif pour sécréter divers facteurs de virulence depuis le périplasme vers le milieu extra-cellulaire. La bactérie phytopathogène Dickeya dadanti (ex. Erwinia chrysanthemi) utilise ce système, appelé Out, pour la sécrétion de pectinases responsable de la maladie de la pourriture molle chez de nombreuses plantes. Les deux composants essentiels du système Out, la protéine de membrane interne OutC et la sécrétine OutD, formant un pore dans la membrane externe, sont impliqués dans la spécificité de sécrétion. L'interaction entre OutC et OutD pourrait assurer l'intégrité structurelle et fonctionnelle du système de sécrétion en reliant les deux membranes. Nous avons entrepris une étude structure-fonction de ces deux composants afin d'identifier et caractériser leurs sites d'interaction et de mieux comprendre leurs rôles. Nous avons appliqué une approche intégrative impliquant une analyse in vivo par cystéine-scanning et pontage disulfure, une analyse in vitro par GST pull down et une analyse structurale d'OutC et OutD et de leurs interactions par RMN. Nos résultats indiquent la présence d'au moins trois sites d'interaction entre les régions périplasmiques d'OutC et d'OutD et suggèrent que ces interactions s'établissent par un mécanisme d'addition des brins β. Nous avons démontré qu'un site situé sur le domaine HR d'OutC pouvait interagir avec deux sites distincts d'OutD suggérant un mode d'interaction alternatif. La présence d'exoprotéines et/ou des composants de membrane interne du système OutE-L-M, modifie différemment l'affinité de ces trois sites d'interaction entre OutC et OutD. Nous proposons que ces interactions alternatives entre divers sites d'OutC et OutD pourraient refléter une succession d'étapes fonctionnelles lors du processus de sécrétion. Pour étudier le mécanisme d'adressage et d'assemblage de la sécrétine OutD dans la membrane externe, nous avons exploité les interactions entre OutD et deux composants auxiliaires du T2SS, la protéine de la membrane interne OutB et la lipoprotéine de la membrane externe OutS. Nous avons montré une interaction directe entre le domaine périplasmique d'OutB et le domaine N0 d'OutD. Une analyse structure-fonction du complexe OutS-OutD a révélé que la pilotine OutS interagit fortement avec 18 résidus à l'extrémité C-terminale de la sécrétine, entraînant la structuration sous forme hélicoïdale de cette région initialement non structurée. Ce travail nous permet de mieux comprendre le mécanisme d'assemblage et de fonctionnement du système de sécrétion de type II.

Le système de sécrétion de type II (T2SS) est largement répandu chez les bactéries à Gram négatif. Il permet la sécrétion d'enzymes lytiques et de toxines. Chez la bactérie phytopathogène Erwinia chrysanthemi, les pectinases, sécrétées par ce système appelé Out, dégradent la pectine, provoquant les symptômes de pourriture molle. La sécrétion par le T2SS se passe en 2 étapes : les protéines traversent la membrane interne par le système Sec ou le système Tat. Une fois dans le périplasme, elles sont repliées et transloquées par le T2SS à travers la membrane externe. Le système Out est composé de 14 protéines intégrées ou associées à l'une des deux membranes. Son assemblage et son fonctionnement restent obscurs. Une plateforme serait formée dans la membrane interne par OutE, -F, -L, -M et -C. Ces trois derniers composants sont des protéines bitopiques dont la stœchiométrie et le rôle sont inconnus. Pour identifier des interactions entre ses composants, nous avons utilisé le double-hybride bactérien, basé sur la reconstitution de l'activité d'adénylate cyclase. Nous avons démontré que le domaine de type ferrédoxine, situé en C-terminus d'OutL et d'OutM, est directement impliqué dans l'homo- et l'hétérodimérisation de ces protéines. Une interaction entre les régions périplasmiques d'OutC et d'OutD a été aussi détectée (Login et al., 2010). Pour mieux analyser les multiples interactions au sein du T2SS, des expériences de triple-hybride ont été réalisées en co-exprimant différentes combinaisons des régions solubles de trois composants. Nos résultats suggèrent qu'OutL empêche l'interaction entre OutC et OutD. Par ailleurs, OutL est impliquée dans l'activation de l'ATPase OutE, le moteur du système (Camberg et al., 2007). OutL serait donc impliquée dans la transmission du signal entre le périplasme et le cytoplasme et pourrait intervenir dans la dissociation du complexe OutD/OutC. Afin d'analyser le rôle des segments transmembranaires (TMS) de composants du T2SS, nous avons adapté la technique du double-hybride. Le domaine de la protéine rapporteur Cya a été fusionné au N-terminus du TMS et BlaM au C-terminus. BlaM sert à contrôler la topologie correcte des fusions dans la membrane. Plusieurs interactions bi-partenaires entre les TMS d'OutC, OutL et OutM ont été ainsi détectées. Ce travail a été complété par une étude in vitro (pull-down) et par mutagenèse dirigée. Ces interactions TMS-TMS pourraient intervenir dans la transmission du signal du périplasme vers le cytoplasme à travers la membrane interne.

This thesis is a series of investigations into the regulation of skeletal muscle mitochondrial metabolism. Novel regulatory mechanisms regarding mitochondrial fatty acid oxidation are continually being identified and alterations in skeletal muscle mitochondrial metabolism have been implicated in the pathogenesis of type II diabetes (T2DM). Therefore, advancing our basic understanding of mitochondrial regulatory processes is required to provide insight into the progression of T2DM. In study one, the utilization of knockout mice for the putative mitochondrial fatty acid transport protein FAT/CD36, showed that mitochondrial FAT/CD36 plays a functional role in mitochondrial long chain fatty acid (LCFA) oxidation. Specifically, FAT/CD36 was found to be located on the outer mitochondrial membrane (OMM) upstream of acyl-CoA synthetase. In study two, it was observed that in rat muscle, malonyl-CoA (M-CoA) inhibition kinetics of carnitine palmitoyltransferase I (CPT-I) display a more physiological IC50 in permeabilzed muscle fibre bundles (PmFB) compared to isolated mitochondria. These data suggest that the cytoskeleton may have a role in regulating M-CoA inhibition. Additionally, a significant effect of LCFA-CoA on M-CoA inhibition kinetics was observed. These data indicate that M-CoA content does not need to decrease to promote an increase in CPT-I flux. Finally, in a model of T2DM (ZDF rat), submaximal ADP-stimulated respiration rates and the content of adenine nucleotide translocase 2 (ANT2) content were depressed compared to lean control animals. Resveratrol treatment in ZDF rats recovered these declines concomitantly with improving insulin-stimulated skeletal muscle glucose uptake and the cellular redox state. A number of novel findings are presented, specifically, 1) a functional role for mitochondrial FAT/CD36 in mitochondrial LCFA oxidation was confirmed and the topology of this protein along the OMM is expanded upon, 2) M-CoA inhibition kinetics of CPT-I were re-evaluated in PmFB and a regulatory role of LCFA-CoA on M-CoA inhibition kinetics is established, and 3) submaximal ADP-stimulated respiration rates and ANT2 content are depressed in the ZDF rat and resveratrol supplementation prevents these decrements.

BACKGROUND: Exercise is a critical treatment modality in persons with Type II Diabetes Mellitus (T2DM), however people with this disease experience chronic fatigue and a decreased exercise capacity, which affects their ability or willingness to participate in physical activity. Studies suggest that this exercise intolerance may be partly due to a reduced exercising muscle blood flow (MBF), and in particular to a reduced ability of red blood cells (RBCs) to evoke ATP-mediated vasodilation and an increase in MBF as they traverse areas of high O2 demand. Additional evidence suggests that caffeine may attenuate this impairment by enhancing the release of ATP from RBCs. HYPOTHESIS: Persons with T2DM would have reduced Forearm Blood Flow (FBF), oxygen consumption (VO2), and exercise tolerance responses to exercise compared to control (CON) subjects, and caffeine would attenuate these impairments. METHODS: T2DM (n = 4) and CON (n = 4) participants performed rhythmic forearm handgrip exercise at an intensity equivalent to 17.5 kg until “task failure” or 20 minutes of exercise was reached, after having consumed either a caffeine (5mg/kg; Caff) or placebo (Pl) capsule. FBF (Doppler and Echo ultrasound of the brachial artery), VO2 and lactate efflux (deep venous blood sampling), forearm vascular conductance (FVK), mean arterial pressure (MAP) and heart rate (HR) were quantified for each minute of exercise. RESULTS: Steady state FBF was similar across groups and treatment conditions (mean ± SE ml/min; CONCaff 553.80 ± 82.35, CONPl 583.42 ± 112.62, T2DMCaff 523.33 ± 105.39, T2DMPl 569.08 ± 134.20, NS), and this was due to similar MAP and FVK (across groups and treatment conditions, NS). VO2 and Time to Task Failure (TTF) were not different between groups and treatment conditions (NS), although TTF tended to be improved with caffeine versus placebo (10.00 ± 2.02 vs 8.24 ± 1.79 min, P=0.295). There was a strong positive relationship between FBF and TTF (r2=0.763; P=0.005). CONCLUSIONS: In the exercise model utilized, persons with T2DM do not have impaired cardiovascular responsiveness or reduced exercise tolerance, and caffeine does not provide any benefit. Differences in exercising MBF may be an underlying mechanism regarding differences in exercise tolerance. / Thesis (Master, Kinesiology & Health Studies) -- Queen's University, 2009-09-16 16:19:42.537